Post Categories
Specialized, Collaborative Clinical Development Services Provide Peace of Mind for Clients
August 18, 2015
Okay, we’ll admit it: a company telling you about their new brochure seems about as interesting as looking through your Great Uncle’s vacation pictures…
First-in-Human, Safety, Tolerability, PK and PD Study of a Rapid Onset Anesthetic: QPS Plays It Safe!
August 28, 2015
QPS was able to deliver on this extremely challenging early phase clinical trial because we have access to the expertise of a university anaesthesiology…
Writing the Book on Beta-Alanine for Sports Performance: QPS MRA’s Doug Kalman Takes a Stand
August 11, 2015
Ever wish that really big hill you always cycle up would seem a little less hilly? Want to swing impressive poundage at your next…
QPS Aids Development of Cannabinoid Chewing Gum, for MS Patients
August 11, 2015
Cannabinoid bioscience has come a long way. New York-based Axim Biotech is at the forefront, developing – among many other, related products – a…
Mental Vacation
August 11, 2015
Need a vacation? Don’t have time? Spend the next 45 seconds pretending you’re here….
Fast Track Routes for Medicines that address Unmet Medical Needs
July 27, 2015
Launch of two-month public consultations on revised guidelines on accelerated assessment and conditional marketing authorization The European Medicines Agency (EMA) has revised its guidelines…
Sports Nutrition Leadership, Benchtop to Countertop: Watch the Webinar on Building Better Beverages with panelist Doug Kalman, Director of Nutrition & Endocrinology at QPS MRA
July 29, 2015
Finding something tasty to drink at the mini-mart has gotten really complicated lately. Knowing the usual soft drinks are unhealthy, you may be tempted…
DMPK scientists from Exelixis and QPS publish on “Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites” in DMD
July 27, 2015
Read the original Exelexis-supported publication in Drug Metabolism & Disposition (DMD). Cabozantinib (COMETRIQ®) inhibits the activity of tyrosine kinases including MET, VEGFRs and RET….
Dr. Diane Krieger from QPS MRA acknowledged in NEJM for her role as investigator in the SCALE Obesity and Prediabetes Study Group
July 27, 2015
The sheer abundance of diet drugs available suggests two things: 1) there is a huge market for them and 2) none of them work…
Hop on the QPS Bioanalysis Bus: Protein Quantitation by LC-MS/MS is Just Around the Corner
July 24, 2015
We love it when you notice! At the recent Sciex Users gathering of MS geeks in the 63th ASMS Annual Conference, one member of…
Regulatory Expertise Now Part of QPS Clinical Development Offerings
July 9, 2015
In July 2015, regulatory expert Patricia Baede joined QPS’ clinical development teams. With 20 years of experience in clinical trial conduct and all regulatory…
3D DNA: Imaging and Sequencing Finally Reveal Genomic Structure
May 2, 2022
Ever since German anatomist Walther Flemming discovered chromosomes in the mid-1800s, scientists have been actively working to decipher the complex organization of these threadlike…
Novel Approaches to Treating Depression
April 27, 2022
Suicide is the second leading cause of death among Americans between the ages of 10 and 34, per the Centers for Disease Control and…
Lab-Grown Fish: Swimming into Sustainability
April 20, 2022
It seems impossible to discuss the fishing industry without also discussing the harm caused by overfishing, overburdened waterways, and concerns about mercury contamination. But…
From Shark Tank to Pharmaceuticals: Billionaire Mark Cuban Makes a Leap for Affordable Medicines
April 4, 2022
Mark Cuban is spearheading an effort to widen Americans’ access to generic pharmaceuticals, adding a direct-to-consumer online pharmacy to the Mark Cuban Cost Plus…
How Can Guidelines Keep Pace with Science? “Living Evidence” May Help
March 28, 2022
Traditionally, the review and updating of medical guidelines have relied on a “systematic review” – a publication following a formal synthesis of data from…
New Draft FDA Guidance on ADC Pharmacology
March 23, 2022
The market for antibody-drug conjugates, or ADCs, is hotter than ever before. In response, the Food and Drug Administration (FDA) released new guidance on clinical…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
